|
1
|
Yung KW, Yung TT and Chung CY: Principles
of cancer staging. Asian Pac J Surg Oncol. 1:1–16. 2015.
|
|
2
|
Sanchez-Carbayo M, Belbin TJ, Scotlandi K,
Prystowsky M, Baldini N, Childs G and Cordon-Cardo C: Expression
profiling of osteosarcoma cells transfected with MDR1 and
NEO genes: regulation of cell adhesion, apoptosis, and tumor
suppression-related genes. Lab Invest. 83:507–517. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liang S and Yang ZL: Expression of KiSS-1
mRNA in pancreatic ductal adenocarcinoma and non-cancerous
pancreatic tissues in SD rats. Zhong Nan Da Xue Xue Bao Yi Xue Ban.
32:109–113. 2007.(In Chinese). PubMed/NCBI
|
|
4
|
Takeda T, Kikuchi E, Mikami S, Suzuki E,
Matsumoto K, Miyajima A, Okada Y and Oya M: Prognostic role of
KiSS-1 and possibility of therapeutic modality of metastin, the
final peptide of the KiSS-1 gene, in urothelial carcinoma.
Mol Cancer Ther. 11:853–863. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Papaoiconomou E, Lymperi M, Petraki C,
Philippou A, Msaouel P, Michalopoulou F, Kafiri G, Vassilakos G,
Zografos G and Koutsilieris M: Kiss-1/GPR54 protein expression in
breast cancer. Anticancer Res. 34:1401–1407. 2014.PubMed/NCBI
|
|
6
|
Jabeen S, Qureshi MZ, Javed Z, Iqbal MJ,
Ismail M and Farooqi AA: Kisspeptin mediated signaling in cancer.
Curr Top Med Chem. 16:2471–2476. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gründker C, Bauerschmitz G, Knapp J,
Schmidt E, Olbrich T and Emons G: Inhibition of SDF-1/CXCR4-induced
epithelial-mesenchymal transition by kisspeptin-10. Breast Cancer
Res Treat. 152:41–50. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang FS, Chen H, Wu ZY and Lin JH: KISS1
expression in osteosarcoma: high in Chinese clinical cases, but
lower in cell lines. Asian Pac J Cancer Prev. 12:3229–3234.
2011.PubMed/NCBI
|
|
9
|
Song GQ and Zhao Y: Kisspeptin 10 inhibits
the Warburg effect in breast cancer through the Smad signaling
pathway: both in vitro and in vivo. Am J Transl Res. 8:188–195.
2016.PubMed/NCBI
|
|
10
|
Castaño JP, Martínez-Fuentes AJ,
Gutiérrez-Pascual E, Vaudry H, Tena-Sempere M and Malagón MM:
Intracellular signaling pathways activated by kisspeptins through
GPR54: do multiple signals underlie function diversity? Peptides.
30:10–15. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Navenot JM, Wang Z, Chopin M, Fujii N and
Peiper SC: Kisspeptin-10-induced signaling of GPR54 negatively
regulates chemotactic responses mediated by CXCR4: a potential
mechanism for the metastasis suppressor activity of kisspeptins.
Cancer Res. 65:10450–10456. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Radwańska P and Kosior-Korzecka U:
Relationships between leptin, KiSS-1/GPR54 expression and TSH
secretion from pituitary cells of pubertal ewes in vitro. Res Vet
Sci. 105:180–187. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Soga T, Lim WL, Khoo AS and Parhar IS:
Kisspeptin activates Ankrd 26 gene expression in migrating
embryonic GnRH neurons. Front Endocrinol (Lausanne).
7:152016.PubMed/NCBI
|
|
14
|
Li WH, Wu HJ, Li YX, Pan HG, Meng T and
Wang X: MicroRNA-143 promotes apoptosis of osteosarcoma cells by
caspase-3 activation via targeting Bcl-2. Biomed Pharmacother.
80:8–15. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin BC, Huang D, Yu CQ, Mou Y, Liu YH,
Zhang DW and Shi FJ: MicroRNA-184 modulates doxorubicin resistance
in osteosarcoma cells by targeting BCL2L1. Med Sci Monit.
22:1761–1765. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu W, Li W, Zhou Y and Zhang C: Inhibition
of beclin1 affects the chemotherapeutic sensitivity of
osteosarcoma. Int J Clin Exp Pathol. 7:7114–7122. 2014.PubMed/NCBI
|
|
17
|
Ma K, Zhang C, Huang MY, Li WY and Hu GQ:
Cinobufagin induces autophagy-mediated cell death in human
osteosarcoma U2OS cells through the ROS/JNK/p38 signaling pathway.
Oncol Rep. 36:90–98. 2016.PubMed/NCBI
|
